{"doc_desc":{"title":"Aquitaine Addiction Cohort: Trajectories of people with addiction (substances or behaviour) in contact with health-care system. Medical, neurobiological, sociological and psychological characteristics. Prospective multicentric, multidisciplinary study","idno":"FRESH-PEF73375-en","producers":[{"name":"Fuschia SERRE","affiliation":""}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF73375-en","IDno":{"metadata_no":[{"agency":"PEF","code":"73375"},{"agency":"FReSH","code":"FRESH-PEF73375"}],"metadata_yes":[{"code":"FReSH","agency":"FReSH"}]},"title":"Aquitaine Addiction Cohort: Trajectories of people with addiction (substances or behaviour) in contact with health-care system. Medical, neurobiological, sociological and psychological characteristics. Prospective multicentric, multidisciplinary study","alternate_title":"ADDICTAQUI"},"study_authorization":{"agency":[{"name":"CNIL"},{"name":"CPP"}]},"authoring_entity":[{"name":"Fuschia;SERRE","firstname":"Fuschia","lastname":"SERRE","type":"investigator","extlink":[{"title":"ORCID","uri":"","role":"pi id"},{"title":"IdRef","uri":"","role":"pi id"},{"title":"ROR","uri":"https:\/\/ror.org\/057qpr032","role":"organisation id"},{"title":"SIREN","uri":"130018351","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}],"email":"fuschia.serre@u-bordeaux.fr","affiliationName":"UNIVERSITE DE BORDEAUX","PILabo":"Universit\u00e9 de Bordeaux \/ Addiction team, SANPSY CNRS USR 3413, Universit\u00e9 de Bordeaux","isContact":true},{"name":"Marc;AURIACOMBE","firstname":"Marc","lastname":"AURIACOMBE","type":"investigator","extlink":[{"title":"ORCID","uri":"","role":"pi id"},{"title":"IdRef","uri":"","role":"pi id"},{"title":"RNSR","uri":"","role":"labo id"}],"email":"marc.auriacombe@u-bordeaux.fr","affiliationName":"CHCP","PILabo":"Charles Perrens Hospital","isContact":true}],"oth_id":[{"name":";","firstname":"","lastname":"","type":"contributor","isContact":"","extlink":[{"title":"ORCID","uri":"","role":"team member id"},{"title":"IdRef","uri":"","role":"team member id"}]},{"name":"","type":"affiliation","teamMemberLabo":"","extlink":[{"title":"RNSR","uri":"","role":"labo id"}]},{"name":"Inclusion centers for this cohort study are the P\u00f4le Addictologie of CH Charles Perrens Bordeaux - CHU de Bordeaux (Prof. M. Auriacombe) and Bizia, CH de la C\u00f4te Basque (Dr J.P. Daulou\u00e8de)","type":"collaboration"}],"production_statement":{"prod_place":"Epidemiology France Portal (PEF)","producers":[{"name":"CENTRE HOSPITALIER CHARLES PERRENS","role":"sponsor","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/04q33ey84","role":"sponsor id"},{"title":"SIREN","uri":"263305849","role":"sponsor id"}]}],"funding_agencies":[{"name":"MINISTERE DE L\u2019ENSEIGNEMENT SUPERIEUR, DE LA RECHERCHE ET DE L\u2019ESPACE","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/03sjk9a61"},{"title":"SIREN","uri":"110044013"}]},{"name":"MINISTERE DU TRAVAIL, DE LA SANTE, DES SOLIDARITES ET DES FAMILLES","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/01wp0c315"},{"title":"SIREN","uri":"130016546"}]}]},"distribution_statement":{"contact":[{"name":"Marc;AURIACOMBE","lastname":"AURIACOMBE","firstname":"Marc","type":"contact","email":"marc.auriacombe@u-bordeaux.fr","affiliationName":"CHCP","contactPointLabo":"Charles Perrens Hospital","extlink":[{"title":"","uri":"","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}]},{"name":"Fuschia;SERRE","lastname":"SERRE","firstname":"Fuschia","type":"contact","email":"fuschia.serre@u-bordeaux.fr","affiliationName":"UNIVERSITE DE BORDEAUX","contactPointLabo":"Universit\u00e9 de Bordeaux \/ Addiction team, SANPSY CNRS USR 3413, Universit\u00e9 de Bordeaux","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/057qpr032","role":"organisation id"},{"title":"SIREN","uri":"130018351","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}]},{"name":"Sarah;MORICEAU","lastname":"MORICEAU","firstname":"Sarah","type":"contact","email":"sarah.moriceau@u-bordeaux.fr","affiliationName":"CENTRE HOSPITALIER CHARLES PERRENS","contactPointLabo":"","extlink":[{"title":"SIREN","uri":"263305849","role":"organisation id"},{"title":"ROR","uri":"https:\/\/ror.org\/04q33ey84","role":"organisation id"},{"title":"RNSR","uri":"","role":"labo id"}]}]},"study_info":{"keywords":[{"keyword":"Addiction"}],"topics":[{"topic":"Addiction medicine","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/42d645e0-f58d-40ed-9917-5b227ff41a92"},{"title":"MeSH","uri":"D000073316"}],"vocab":"health theme"},{"topic":"Disorders due to substance use","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/590211325"}]},{"topic":"Gambling disorder","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1041487064"}]},{"topic":"Video gaming disorder","vocab":"cim-11","extLink":[{"title":"CIM-11","uri":"http:\/\/id.who.int\/icd\/entity\/1107599126"}]},{"topic":"Socio-demographic and economic determinants","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Employment","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Income","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Housing","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Education level","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Family situation","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Gender","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Age","vocab":"health determinant"},{"topic":"Socio-demographic and economic determinants: Other","vocab":"health determinant"},{"topic":"Healthcare system determinants","vocab":"health determinant"},{"topic":"Healthcare system determinants: Use of care","vocab":"health determinant"},{"topic":"Behavioral determinants","vocab":"health determinant"},{"topic":"Behavioral determinants: Addiction","vocab":"health determinant"},{"topic":"Other","vocab":"health determinant"}],"purpose":"The main objective of this study is to assess the medium- and long-term impact of addiction treatment. This is a medium- and long-term impact study under naturalistic conditions. This impact is evaluated on different parameters in a multidimensional way, depending on the subjects (medical and biopsychosocial characteristics), the therapeutic frameworks and their organisation, or the general context, in order to determine the trajectories. We seek to understand these trajectories and predict them from multiple characteristics (medical, neurobiological, sociological, psychological). A secondary objective is to study the socio-cultural and psychopathological profiles of the subjects according to the type of addiction they present at inclusion. We will try, in particular, to highlight similarities and differences depending on the type of addiction. Ultimately, it is a question of being able to intervene more effectively for prevention and therapeutics but also to gain a better understanding of the development of addictive behaviour and the choice of a preferential substance or behaviour.","abstract":"A prospective, multicenter, open-label study launched in 1994 to monitor individuals still receiving treatment for all types of addiction (substance or behavioral) and to assess the medium- and long-term impact of treatment at specialized addiction treatment centers. The study plan is a prospective, multicentric study that includes participants with substance addiction and\/or behavioural addiction when they request treatment for their addiction. ","coll_dates":[{"start":"1994-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}}],"geog_coverage":"['Nouvelle-Aquitaine']","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D005260\"\n            },\n            \"value\": \"Female\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D008297\"\n            },\n            \"value\": \"Male\"\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D055815\"\n            },\n            \"value\": \"Young Adult (19 to 24 years)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D000328\"\n            },\n            \"value\": \"Adult (25 to 44 years)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D008875\"\n            },\n            \"value\": \"Middle Aged (45 to 64 years)\"\n        },\n        {\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"D000368\"\n            },\n            \"value\": \"Aged (65 to 79 years)\"\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients population\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"To be included in the cohort, subjects must meet the DSM-5 diagnostic criteria for substance-related and addictive disorders (substance or non-substance addiction). They should seek a treatment for their addiction and agree to participate in this study.\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Biological data','Socio-demographic data','Participant-reported health data']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Severity of addiction"},{"activity_type":"secondary evaluation","activity_description":""}]},"method":{"data_collection":{"time_method":"Prospective longitudinal","frequency":"Samples are collected at the start of treatment, at 3 months, 6 months, and then every 6 months.","sampling_procedure":"['{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Other\"},\"value\":\"Other\"}']","sample_frame":{"frame_unit":{"unit_type":"['Through organizations (health services or institutions, schools, businesses, etc.)']"}},"coll_mode":["{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Transcription\"},\"value\":\"Converting or copying information into a structured record\"}","{\"concept\":{\"vocab\":\"CESSDA\",\"vocabURI\":\"Interview\"},\"value\":\"Interview with the participant (including clinical)\"}"],"research_instrument":"Access on specific project only","sources":[{"sourceCitation":{"titlStmt":{"titl":""},"holdings":"","notes":{"subject":"source purpose","value":""}},"srcOrig":[]}],"target_sample_size":"[1000-10000[ individuals","response_rate":"2016: 3500 inclus"},"method_notes":"Observational Study","study_class":"Ongoing study","notes":[{"subject":"research type","values":["Observational Study"]},{"subject":"observational study method","values":["Cohort study"]},{"subject":"follow-up","values":["Monitoring by contact with the participant (mail, e-mail, telephone etc.)","Monitoring by participant visit to the investigation center"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"extLink\":{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"},\"value\":\"Restricted access\"}"},"dataset_use":{"restrictions":"","conditions":"Contact the principal investigator","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":"Marc;AURIACOMBE","firstname":"Marc","lastname":"AURIACOMBE","email":"marc.auriacombe@u-bordeaux.fr"}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":false,"versionLang":"en","originLang":"en","lastUpdatedAuto":"15-06-2026","lastUpdatedManual":"15-06-2026","autoTranslation":false,"status":"Awaiting validation","respValidation":"","isHealthTheme":true,"isContributorPI":false,"addTeamMember":"","primaryInvestigator":{"isPIContact":true,"piMail":"marc.auriacombe@u-bordeaux.fr","piAffiliation":{"piLabo":"Charles Perrens Hospital"}},"relatedDocument":[],"contactPointLabo":"","obtainedAuthorization":{"otherAuthorizingAgency":["",""]},"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":["Public (France)","Public (France)"],"otherFundingAgentType":["",""]},"sponsor":{"sponsorType":["Public (France)"],"otherSponsorType":[""]},"governance":{"committee":false},"collaborations":{"networkConsortium":true},"theme":{"complementaryInformation":"","RareDiseases":false},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":false,"allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[{"name":"Addiction","type":"","typeOther":""}],"cohortLongitudinal":{"recrutementTiming":[]},"otherResearchType":{"otherResearchTypeDetails":""},"inclusionGroups":[],"nrInclusionGroups":false,"collectionProcess":{"collectionModeDetails":"","collectionModeOther":""},"dataCollection":{"inclusionStrategy":[],"samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"activeFollowUp":{"isActiveFollowUp":true,"followUpModeOther":""},"dataCollectionIntegration":{"isDataIntegration":false},"geographicalCoverage":{"geoDetail":"Aquitaine"},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"Urinary toxicity dosage","isDataInBiobank":false,"biobankContent":[],"biobankContentOther":"","dataTypeOther":"","paraclinicalDataOther":"","otherLiquidsDetails":""},"variableDictionnary":{"variableDictionnaryAvailable":false,"variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[""]},"fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}